The FDA-Approved Drug Pyrvinium Selectively Targets ER+ Breast Cancer Cells with High INPP4B Expression
Samuel J. Rodgers(Oslo University Hospital), Christina A. Mitchell(Discovery Institute)
Cited by 7
Related Papers
Identification of FHL1 as a regulator of skeletal muscle mass: implications for human myopathy
|The Journal of Cell Biology|2008|134
Regulation of the Transcriptional Coactivator FHL2 Licenses Activation of the Androgen Receptor in Castrate-Resistant Prostate Cancer
|Cancer Research|2013|57
Inpp5e suppresses polycystic kidney disease via inhibition of PI3K/Akt-dependent mTORC1 signaling
|Human Molecular Genetics|2016|57
PtdIns(3,4,5)P3-dependent Rac Exchanger 1 (PREX1) Rac-Guanine Nucleotide Exchange Factor (GEF) Activity Promotes Breast Cancer Cell Proliferation and Tumor Growth via Activation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2) Signaling
|Journal of Biological Chemistry|2016|32
Superresolution Microscopy Reveals Distinct Phosphoinositide Subdomains Within the Cilia Transition Zone
|Frontiers in Cell and Developmental Biology|2021|30